Skip to main content
SpringerLink
Log in

Development and Validation of a HPLC Method for Dissolution and Stability Assay of Liquid-Filled Cyclosporine Capsule Drug Products

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

To assay the dissolution samples of a drug product from several sources, a simple but broadly applicable analytical method is always desired. For the liquid-filled cyclosporine capsules, while analyzing the dissolution samples, the current compendial and literature HPLC methods have been found to be inadequate to provide satisfactory separation of the drug and the excipient peaks. Accordingly, a suitable isocratic reverse-phase HPLC method was developed for the analysis of dissolution samples of liquid-filled cyclosporine capsules. The method successfully separated the cyclosporine peak from the interfering chromatographic peaks of the excipients. The method was validated according to the ICH and FDA guidelines. Specificity, selectivity, linearity, accuracy, precision, and robustness were established over 3 days as part of method validation. Additionally, the degradation kinetics of cyclosporine in dissolution media was determined. Cyclosporine degradation followed a zero-order kinetics in the dissolution media with the respective rate constants of −3.5, −1.5, and −0.3%/h at 37°C, 25°C, and 10°C.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Talal N. Cyclosporine as an immunosuppressive agent for autoimmune disease: theoretical concepts and therapeutic strategies. Transplant Proc. 1988;20(3 Suppl 4):11–5.

    PubMed  CAS  Google Scholar 

  2. D. Tedesco, L. Haragsim. Cyclosporine: a review. Journal of Transplantation 2012;230386. 2012.

  3. Drugs@FDA. 2012.

  4. Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res. 1996;13(1):163–7. Springer Netherlands.

    Article  PubMed  CAS  Google Scholar 

  5. Friis GJ, Bundgaard H. Kinetics of degradation of cyclosporin A in acidic aqueous solution and its implication in its oral absorption. Int J Pharm. 1992;82(1–2):79–83.

    Article  CAS  Google Scholar 

  6. Kahan BD, Grevel J. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation. 1988;46(5):631–44.

    Article  PubMed  CAS  Google Scholar 

  7. Grevel J, Nuesch E, Abisch E, Kutz K. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects. Eur J Clin Pharmacol. 1986;31(2):211–6.

    Article  PubMed  CAS  Google Scholar 

  8. Kahan BD. Therapeutic drug monitoring of cyclosporine: 20 years of progress. Transplant Proc. 2004;36(2, Supplement):S378–91.

    Article  Google Scholar 

  9. Honcharik N. The effect of food on cyclosporine absorption. Selected papers from the Canadian Consensus Meeting on Cyclosporine Monitoring. Clin Biochem. 1991;24(1):89–92.

    Article  PubMed  CAS  Google Scholar 

  10. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107(4):631–9.

    Article  PubMed  CAS  Google Scholar 

  11. Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res. 1989;6(1):40–3. Springer Netherlands.

    Article  PubMed  CAS  Google Scholar 

  12. Keown P, Niese D. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. Kidney Int. 1998;54(3):938–44.

    Article  PubMed  CAS  Google Scholar 

  13. Tredger JM. Using cyclosporine neoral immediately after liver transplantation. Therapeutic Drug Monitoring 1995;17[6]

  14. Bowers LD, Mathews SE. Investigation of the mechanism of peak broadening observed in the high-performance liquid chromatographic analysis of cyclosporine. J Chromatogr A. 1985;333(0):231–8.

    CAS  Google Scholar 

  15. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA. Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci. 2007;96(9):2409–23. Wiley Subscription Services, Inc., A Wiley Company.

    Article  PubMed  CAS  Google Scholar 

  16. Kumar M, Singhal SK, Singh A. Development and validation of a stability indicating HPLC assay method for cyclosporine in cyclosporine oral solution USP. J Pharm Biomed Anal. 2001;25(1):9–14.

    Article  PubMed  CAS  Google Scholar 

  17. ICH Q2(R1) Validation of analytical procedures: text and methodology;1995.

  18. Hansch C, Leo A, Hoekman DH. Exploring QSAR. Washington, DC: American Chemical Society;1995

Download references

Acknowledgments

This project was funded by regulatory science and review enhancement (RSR) funding from FDA, and was supported in part by an appointment to the ORISE Research Participation Program at the CDER administered by the Oak Ridge Institute for Science and Education through an agreement between the U.S. Department of Energy and CDER.

Disclaimer

The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.

Author information

Authors and Affiliations

  1. Division of Product Quality Research, OTR/OPS, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, USA

    Xiaoming Xu, Abhay Gupta, Patrick Faustino & Mansoor A. Khan

  2. Office of Generic Drugs, OPS, 7500 Standish Place, Rockville, Maryland, 20855, USA

    Pradeep M. Sathe & Vilayat A. Sayeed

Authors
  1. Xiaoming Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhay Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick Faustino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pradeep M. Sathe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vilayat A. Sayeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mansoor A. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mansoor A. Khan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, X., Gupta, A., Faustino, P. et al. Development and Validation of a HPLC Method for Dissolution and Stability Assay of Liquid-Filled Cyclosporine Capsule Drug Products. AAPS PharmSciTech 14, 959–967 (2013). https://doi.org/10.1208/s12249-013-9983-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-013-9983-8

Key words

Search

Navigation